Eduardo Tolosa

Eduardo Tolosa Alsina was a Spanish professor of calligraphy and gymnastics educator who founded the ''Gimnàs Tolosa'' in the 1880s under the name ''Gimnasio Médico'', a Barcelona multi-sport gymnasium. Toghet with his wife Emília Colomer, he was a pioneer in women's gymnastics, being the director of a recreational Gymnasium for both sexes and with separate departments in the 1890s. Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'Eduardo Tolosa', query time: 0.06s Refine Results
  1. 1
    Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's diseaseResearch in context

    Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's diseaseResearch in context by Petar Podlesniy, Margalida Puigròs, Núria Serra, Rubén Fernández-Santiago, Mario Ezquerra, Eduardo Tolosa, Ramon Trullas

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients

    Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients by Ariadna Recasens, Iria Carballo-Carbajal, Annabelle Parent, Jordi Bové, Ellen Gelpi, Eduardo Tolosa, Miquel Vila

    Published 2018-02-01
    Get full text
    Article
  3. 3
    Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease

    Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson’s Disease by Emilio Fernández-Espejo, Fernando Rodríguez de Fonseca, Juan Suárez, Eduardo Tolosa, Dolores Vilas, Iban Aldecoa, Joan Berenguer, Fátima Damas-Hermoso

    Published 2021-05-01
    Get full text
    Article
  4. 4
    Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease

    Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease by Margalida Puigròs, Anna Calderon, Alexandra Pérez-Soriano, Cristina de Dios, Manel Fernández, Anna Colell, Maria-José Martí, Eduardo Tolosa, Ramon Trullas

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels

    Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels by Rubén Fernández-Santiago, Anna Esteve-Codina, Manel Fernández, Francesc Valldeoriola, Almudena Sanchez-Gómez, Esteban Muñoz, Yaroslau Compta, Eduardo Tolosa, Mario Ezquerra, María J. Martí

    Published 2021-12-01
    Get full text
    Article
  6. 6
    Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder

    Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder by Ariadna Laguna, Helena Xicoy, Eduardo Tolosa, Mònica Serradell, Dolores Vilas, Carles Gaig, Manel Fernández, Oscar Yanes, Joan Santamaria, Núria Amigó, Alex Iranzo, Miquel Vila

    Published 2021-05-01
    Get full text
    Article
  7. 7
    Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease

    Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ́s disease by Emilio Fernández-Espejo, Ana L. Gavito, Juan Suárez, Eduardo Tolosa, Dolores Vilas, Iban Aldecoa, Joan Berenguer, Antonio Córdoba-Fernández, Fátima Damas-Hermoso, Fernando Rodríguez de Fonseca

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes

    Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes by Irene Lobon, Manuel Solís-Moruno, Manuel Solís-Moruno, David Juan, Ashraf Muhaisen, Ashraf Muhaisen, Federico Abascal, Paula Esteller-Cucala, Raquel García-Pérez, Maria Josep Martí, Maria Josep Martí, Eduardo Tolosa, Eduardo Tolosa, Jesús Ávila, Jesús Ávila, Raheleh Rahbari, Tomas Marques-Bonet, Tomas Marques-Bonet, Tomas Marques-Bonet, Tomas Marques-Bonet, Ferran Casals, Ferran Casals, Eduardo Soriano, Eduardo Soriano

    Published 2022-04-01
    Get full text
    Article
  9. 9
    The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II

    The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II by José-Francisco Rocha, Georg Ebersbach, Andrew Lees, Eduardo Tolosa, Joaquim J. Ferreira, Werner Poewe, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, Diogo Magalhães, Helena Gama, Patrício Soares-da-Silva

    Published 2021-11-01
    Get full text
    Article
  10. 10
    The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II

    The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II by José-Francisco Rocha, Georg Ebersbach, Andrew Lees, Eduardo Tolosa, Joaquim J. Ferreira, Werner Poewe, Olivier Rascol, Fabrizio Stocchi, Angelo Antonini, Diogo Magalhães, Helena Gama, Patrício Soares-da-Silva

    Published 2022-08-01
    Get full text
    Article
  11. 11
    Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease.

    Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease. by Carles Gaig, Dolores Vilas, Jon Infante, María Sierra, Inés García-Gorostiaga, Mariateresa Buongiorno, Mario Ezquerra, Maria José Martí, Francesc Valldeoriola, Miquel Aguilar, Matilde Calopa, Jorge Hernandez-Vara, Eduardo Tolosa

    Published 2014-01-01
    Get full text
    Article
  12. 12
    Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

    Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease by Angelique di Domenico, Giulia Carola, Carles Calatayud, Meritxell Pons-Espinal, Juan Pablo Muñoz, Yvonne Richaud-Patin, Irene Fernandez-Carasa, Marta Gut, Armida Faella, Janani Parameswaran, Jordi Soriano, Isidro Ferrer, Eduardo Tolosa, Antonio Zorzano, Ana Maria Cuervo, Angel Raya, Antonella Consiglio

    Published 2019-02-01
    Get full text
    Article
  13. 13
    Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease

    Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease by Marta Soto, Manel Fernández, Paloma Bravo, Sara Lahoz, Alicia Garrido, Antonio Sánchez-Rodríguez, María Rivera-Sánchez, María Sierra, Paula Melón, Ana Roig-García, Anna Naito, Bradford Casey, Jordi Camps, Eduardo Tolosa, María-José Martí, Jon Infante, Mario Ezquerra, Rubén Fernández-Santiago

    Published 2023-02-01
    Get full text
    Article
  14. 14
    WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes

    WHOPPA Enables Parallel Assessment of Leucine-Rich Repeat Kinase 2 and Glucocerebrosidase Enzymatic Activity in Parkinson’s Disease Monocytes by Rebecca L. Wallings, Rebecca L. Wallings, Laura P. Hughes, Hannah A. Staley, Hannah A. Staley, Zachary D. Simon, Nikolaus R. McFarland, Roy N. Alcalay, Roy N. Alcalay, Alicia Garrido, María José Martí, Eduardo Tolosa Sarró, Nicolas Dzamko, Malú Gámez Tansey, Malú Gámez Tansey, Malú Gámez Tansey

    Published 2022-06-01
    Get full text
    Article
  15. 15
    Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease

    Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease by Sara Gomes, Alicia Garrido, Francesca Tonelli, Donina Obiang, Eduardo Tolosa, Maria José Martí, Javier Ruiz-Martínez, Ana Vinagre-Aragón, Haizea Hernandez-Eguiazu, Ioana Croitoru, Vicky L. Marshall, Theresa Koenig, Christoph Hotzy, Frank Hsieh, Marianna Sakalosh, Elizabeth Tengstrand, Shalini Padmanabhan, Kalpana Merchant, Christof Bruecke, Walter Pirker, Alexander Zimprich, Esther Sammler

    Published 2023-04-01
    Get full text
    Article
  16. 16
    Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus

    Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus by Diana Luz Juárez-Flores, Mario Ezquerra, ïngrid Gonzàlez-Casacuberta, Aida Ormazabal, Constanza Morén, Eduardo Tolosa, Raquel Fucho, Mariona Guitart-Mampel, Mercedes Casado, Francesc Valldeoriola, Joan de la Torre-Lara, Esteban Muñoz, Ester Tobías, Yaroslau Compta, Francesc Josep García-García, Carmen García-Ruiz, Jose Carlos Fernandez-Checa, Maria José Martí, Josep Maria Grau, Francesc Cardellach, Rafael Artuch, Rubén Fernández-Santiago, Glòria Garrabou

    Published 2020-10-01
    Get full text
    Article

Search Tools: